오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

vetpharm laboratories ip pty ltd - lincomycin as lincomycin hydrochloride; spectinomycin as spectinomycin sulfate - parenteral liquid/solution/suspension - lincomycin as lincomycin hydrochloride antibiotic active 50.0 mg/ml; spectinomycin as spectinomycin sulfate antibiotic active 100.0 mg/ml - antibiotic & related

오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

abbey laboratories pty ltd - lincomycin hydrochloride - oral powder, pre-mix - lincomycin hydrochloride antibiotic active 1000.0 g/kg - antibiotic & related

오스트레일리아 - 영어 - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - lincomycin hydrochloride monohydrate, quantity: 340.26 mg/ml (equivalent: lincomycin, qty 300 mg/ml) - injection, solution - excipient ingredients: benzyl alcohol; water for injections - indications as at 22 september 1994: lincocin is indicated in the treatment of serious infections due to susceptible strains of gram positive aerobes such as streptococci, pneumococci and staphylococci. its use should be reserved for penicillin allergic patients or other patients for whom, in the judgement of the physician, a penicillin is inappropriate. because of the risk of colitis (see precautions), before selecting lincomycin the physician should consider the nature of infection and the suitability of less toxic alternatives (e.g.erythromycin). lincocin has been demonstrated to be effective in the treatment of staphylococcal infections resistant to other antibiotics and susceptible to lincomycin. staphylococcal strains resistant to lincocin have been recovered; culture and susceptibility studies should be done in conjunction with lincocin therapy. in the case of macrolides, partial but not complete cross resistance may occur. the drug may be administered concomitantly with other antimicrobial agents with

뉴질랜드 - 영어 - Medsafe (Medicines Safety Authority)

viatris limited - erythromycin ethylsuccinate 482mg equivalent to erythromycin 400 mg (plus 3% overage) - film coated tablet - 400 mg - active: erythromycin ethylsuccinate 482mg equivalent to erythromycin 400 mg (plus 3% overage) excipient: calcium hydrogen phosphate magnesium stearate maize starch opadry pink oy-b-34901 povidone purified talc purified water sodium starch glycolate sorbic acid - streptococcus pyogenes (group a beta-haemolytic streptococcus): upper and lower respiratory tract, skin and soft tissue infections of mild to moderate severity. when oral medication is preferred for treatment of streptococcal pharyngitis and in long term prophylaxis of rheumatic fever, erythromycin is an alternate drug of choice. when oral medication is given, the importance of strict adherence by the patient to the prescribed dosage regimen must be stressed. a therapeutic dose should be administered for at least 10 days. prevention of initial attacks of rheumatic fever: penicillin is considered to be the drug of choice in the prevention of initial attacks of rheumatic fever (treatment of group a beta-haemolytic streptococcal infections of the upper respiratory tract e.g. tonsillitis or pharyngitis). erythromycin is indicated for the treatment of penicillin-allergic patients. the therapeutic dose should be administered for 10 days. prevention of recurrent attacks of rheumatic fever: penicillin or sulphonamides are considered to be the drugs of choice in the prevention of recurrent attacks of rheumatic fever. in patients who are allergic to penicillin and sulphonamides, oral erythromycin is recommended in the long term prophylaxis of streptococcal pharyngitis (for the prevention of recurrent attacks of rheumatic fever).

싱가포르 - 영어 - HSA (Health Sciences Authority)

yung shin pharmaceutical (singapore) pte ltd - lincomycin hcl eqv lincomycin - injection - 300 mg/ml - lincomycin hcl eqv lincomycin 300 mg/ml

싱가포르 - 영어 - HSA (Health Sciences Authority)

zyfas pharma pte ltd - lincomycin hcl eqv lincomycin - injection - 300 mg/ml - lincomycin hcl eqv lincomycin 300 mg/ml

아일랜드 - 영어 - HPRA (Health Products Regulatory Authority)

chanelle pharmaceuticals manufacturing limited - lincomycin hydrochloride; spectinomycin sulfate tetrahydrate - solution for injection - 50, 100 milligram(s)/millilitre - lincomycin, combinations - cats, cattle, dogs, pigs - antibacterial

오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

south yarra pharma pty ltd - lincomycin hydrochloride - unknown - lincomycin hydrochloride antibiotic active 0.0 - active constituent

오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - lincomycin hydrochloride - unknown - lincomycin hydrochloride antibiotic active 0.0 - active constituent

오스트레일리아 - 영어 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - lincomycin hydrochloride - unknown - lincomycin hydrochloride antibiotic active 0.0 - active constituent